ResearcherSun Yat-sen UniversityActive in the last 2 years
Ping‐Pui Wong
Matched on ORCID iD 0000-0003-1592-4823; OpenAlex author ID A5007098457. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2022: 1 paper · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Tailoring Vascular-Immune Homeostasis via Manganese-DNA Complex-Armed Immunogenic Extracellular Vesicles for Pancreatic Cancer Immunotherapy. Last author DOI 10.1002/advs.202507159↗
- Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models. Last author DOI 10.1126/scitranslmed.abl7895↗
- Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk. Last author DOI 10.1186/s12967-023-04519-3↗
- Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment. Co-author DOI 10.1158/0008-5472.can-20-3807↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xue Jiang · 3 shared papers, 2023–2026 · strength 0.59
- Paper Tailoring Vascular-Immune Homeostasis via Manganese-DNA Complex-Armed Immunogenic Extracellular Vesicles for Pancreatic… DOI 10.1002/advs.202507159↗
- Paper Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-… DOI 10.1186/s12967-023-04519-3↗
- Paper Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models. DOI 10.1126/scitranslmed.abl7895↗
- Hongquan Qin · 1 shared paper, 2023 · strength 0.18
- Liangping Su · 1 shared paper, 2023 · strength 0.16
- Marina Roy-Luzarraga · 1 shared paper, 2022 · strength 0.12
- Kairbaan Hodivala‐Dilke · 1 shared paper, 2022 · strength 0.12
- Victoria Sanz‐Moreno · 1 shared paper, 2022 · strength 0.12
- Frances M. Richards · 1 shared paper, 2022 · strength 0.12
- Dieter Saur · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.